Chromogranin A predicts survival for resected pancreatic neuroendocrine tumors

详细信息    查看全文

• 作者：Matthew A. Shanahan ; BS ; Ahmed Salem ; MD ; Alexander Fisher ; MD ; Clifford S. Cho ; MD ; Glen Leverson ; PhD ; Emily R. Winslow ; MD ; Sharon M. Weber ; MD ; ^{webers@surgery.wisc.edu" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Pancreatic neuroendocrine tumor ; Chromogranin A ; Survival
• 刊名：Journal of Surgical Research
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：201
• 期：1
• 页码：38-43
• 全文大小：446 K

文摘

Currently, no serological prognostic marker exists for pancreatic neuroendocrine tumors (pNETs). Previous studies have suggested potential for chromogranin A (CgA); however, the prognostic capability of CgA remains controversial. Our purpose was to explore preoperative CgA levels in predicting outcomes in patients with resected pNETs.

d="absSec_2">Materials and methods

d="abspara0015">Patients with preoperative CgA levels who underwent resection of a pancreatic neuroendocrine tumor between July 2002 and May 2013 were identified from a prospective database. An elevated preoperative CgA was defined as a CgA laboratory value above the normal limit of the assay. All patients had pathologically confirmed primary pancreatic tumors. Outcomes were compared between elevated and normal CgA groups.

d="absSec_3">Results

d="abspara0020">A total of 38 patients were identified that met inclusion criteria. Of these, 45% were male, and the median age was 57 y (range, 17–81 y). All underwent resection with curative intent. Elevated preoperative CgA was present in 16 patients (42%). There were no differences in node positivity or margin status between the normal CgA and elevated CgA groups on univariate analysis. However, tumor size and grade were significantly different between the two groups. Both disease-free survival (DFS; P = 0.006) and overall survival (P = 0.017) were negatively impacted by an elevated preoperative CgA (median follow-up; 40 mo).

d="absSec_4">Conclusions

d="abspara0025">In patients with resected pNETs, an elevated preoperative CgA level was negatively associated with DFS and OS and was the only independent predictor of DFS. These results indicate that preoperative CgA may be a clinically useful prognostic marker for patients undergoing pancreatic neuroendocrine tumor resection.